东北制药：聘任李新为公司财务总监

Company Announcement - Northeast Pharmaceutical announced the appointment of Ms. Li Xin as the new Chief Financial Officer, following the approval of the board's nomination committee and audit committee [1] Financial Performance - For the first half of 2025, Northeast Pharmaceutical's revenue composition is as follows: 52.0% from pharmaceutical manufacturing, 46.18% from pharmaceutical commerce, and 1.82% from other industries [1] - The current market capitalization of Northeast Pharmaceutical is 8.1 billion yuan [1]